We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Researchers Find Additional Genes Responsible for Foul Odor Disorder

By LabMedica International staff writers
Posted on 28 Feb 2017
Print article
Image: By comparing sensory, metabolic, and genetic data from patients with trimethylaminura (TMAU), researchers found that the cause of TMAU in some patients is likely due to mutations in genes other than FMO3 (Photo courtesy of the Monell Center).
Image: By comparing sensory, metabolic, and genetic data from patients with trimethylaminura (TMAU), researchers found that the cause of TMAU in some patients is likely due to mutations in genes other than FMO3 (Photo courtesy of the Monell Center).
A study using whole exome sequencing of patients with trimethylaminura (TMAU) may to lead to additional diagnostic criteria and therapeutic targets for this rare metabolic disorder, which until now has been generally attributed solely to mutations in the FMO3 gene.

The study, led by researchers from the Monell Center, provides new insight into genetically transmitted TMAU, a metabolic disorder due to accumulation of trimethylamine (TMA) in people with impaired TMA metabolism. TMAU is classified as a “rare disease” in that it affects less than 200,000 people in the United States, but its actual incidence remains uncertain in part due to inconclusive diagnostic techniques.

“Our findings may bring some reassurance to people who report fish-like odor symptoms but do not have mutations in the FMO3 gene,” said co-senior author Danielle R. Reed, PhD, of Monell Center.

The socially and psychologically distressing odor symptoms result from the buildup TMA produced naturally from many foods rich in choline (e.g. eggs, certain legumes, wheat germ, saltwater fish, organ meats). TMA, which has a foul odor reminiscent of rotting fish, normally is metabolized by the liver enzyme flavin-containing monooxygenase 3 (FMO3) into an odorless metabolite. People with TMAU are unable to metabolize TMA, which accumulates and is excreted from the body in urine, sweat, saliva, and breath.

Some people who report having the fish odor symptoms do not have severely disruptive mutations in the FMO3 gene. This led the researchers to suspect that testing for FMO3 mutations is likely insufficient in that other genes may also contribute to the disorder. In the study, they combined exome analysis with computer modeling to probe for additional TMAU-related genes. They compared sensory, metabolic, and genetic data from 10 individuals randomly selected from 130 subjects previously evaluated for TMAU at Monell Center. The metabolic test measured production of TMA following ingestion of choline. Each subject’s body odor was evaluated by a trained sensory panel before and after the choline challenge test.

Although the choline challenge test confirmed a diagnosis of TMAU by revealing a high level of urinary TMA in all 10 subjects, genetic analyses revealed that the FMO3 gene appeared to be normal in 4 of the 10. Additional analyses revealed defects in several other genes that could contribute to the inability to metabolize TMA.

“These new genes may help us better understand the underlying biology of the disorder and perhaps even identify treatments,” said Dr. Reed.

Although all of the subjects reported frequent fish-odor symptoms, none was judged by the sensory panel to have a fish-like odor at the time of the choline challenge. TMAU’s odor symptoms can occur in irregular and seemingly unpredictable intervals, which often adds to the difficulty of diagnosis.

Co-senior author George Preti, PhD, of Monell, commented on the diagnostic implications of the combined findings: “Regardless of either the patient’s current sensory presentation or FMO3 genetics, the choline challenge test will confirm the TMA accumulation that reveals the presence of the disorder.”

The researchers would like to repeat the genetic analyses in a larger cohort of TMAU patients without FMO3 mutations to investigate which other genes are involved in the disorder. “Such information may identify additional odorants produced by TMAU-positive patients, and inform the future development of gene-based therapies,” said Dr. Preti.

The study, by Guo Y et al, was published February 15, 2017, in the journal BMC Medical Genetics.

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.